Pancreatic Cancer Research

ResearcherKansai Medical UniversityActive in the last 2 years

Hisato Igarashi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112009256. Sources: OpenAlex.

Their work

Papers
12
Trials
0
Grants
0
Labs led
0
Collaborators
71
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 2 papers · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 12

  1. Three Molecular Developmental Pathways of Remnant Pancreatic Cancer After Resection: A Nationwide Project Study of Japan Pancreas Society. Co-author DOI 10.1097/sla.0000000000006444↗
  2. Impact of S-1 adjuvant chemotherapy longer than 6 months on survival in patients with resected pancreatic cancer: a nationwide survey by the Japan Pancreas Soc… Co-author DOI 10.1002/cncr.34580↗
  3. Collision of a pancreatic ductal adenocarcinoma and a pancreatic neuroendocrine tumor associated with multiple endocrine neoplasm type 1. Co-author DOI 10.1007/s12328-020-01234-0↗
  4. Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study. Co-author DOI 10.1097/mpa.0000000000001579↗
  5. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nat… Co-author DOI 10.1016/j.surg.2019.06.023↗
  6. Clinicopathological Characteristics of Young Patients With Pancreatic Cancer: An Analysis of Data From Pancreatic Cancer Registry of Japan Pancreas Society. Co-author DOI 10.1097/mpa.0000000000000636↗
  7. Predictors and Diagnostic Strategies for Early-Stage Pancreatic Ductal Adenocarcinoma: A Retrospective Study. Co-author DOI 10.1097/mpa.0000000000000393↗
  8. [Lifestyle and the risk of pancreatic cancer]. Co-author PMID 25857060↗
  9. Role of ERCP in the era of EUS-FNA for preoperative cytological confirmation of resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00595-014-0845-0↗
  10. Key endoscopic ultrasound features of pancreatic ductal adenocarcinoma smaller than 20 mm. Co-author DOI 10.3109/00365521.2013.878745↗
  11. Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm … Co-author DOI 10.1007/s00534-012-0541-7↗
  12. Paclitaxel-based chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy failure: a case series of 5 patients. Co-author DOI 10.1159/000334704↗

Closest collaborators

The 25 strongest of 71 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tamotsu Kuroki · 5 shared papers, 2016–2025 · strength 0.49
  2. Sohei Satoi · 5 shared papers, 2016–2025 · strength 0.49
  3. Hidetoshi Eguchi · 5 shared papers, 2016–2025 · strength 0.49
  4. Hiroki Yamaue · 5 shared papers, 2016–2025 · strength 0.49
  5. Masaji Tani · 5 shared papers, 2016–2025 · strength 0.49
  6. Atsushi Masamune · 5 shared papers, 2016–2025 · strength 0.49
  7. Tsutomu Fujii · 5 shared papers, 2016–2025 · strength 0.49
  8. Yoshiki Hirooka · 5 shared papers, 2016–2025 · strength 0.49
  9. Michiaki Unno · 4 shared papers, 2016–2025 · strength 0.40
  10. Tomohisa Yamamoto · 3 shared papers, 2020–2025 · strength 0.37
  11. Kazuichi Okazaki · 3 shared papers, 2019–2025 · strength 0.31
  12. Yoshifumi Takeyama · 2 shared papers, 2023–2025 · strength 0.29
  13. Yuichi Nagakawa · 2 shared papers, 2023–2025 · strength 0.29
  14. Satoshi Hirano · 2 shared papers, 2020–2025 · strength 0.24
  15. Yoshinao Oda · 4 shared papers, 2014–2021 · strength 0.23
  16. Takao Ohtsuka · 4 shared papers, 2013–2021 · strength 0.22
  17. Takao Itoi · 3 shared papers, 2016–2020 · strength 0.20
  18. Masao Tanaka · 5 shared papers, 2013–2016 · strength 0.19
  19. Tetsuhide Ito · 2 shared papers, 2015–2021 · strength 0.18
  20. Kenichi Hakamada · 1 shared paper, 2025 · strength 0.16
  21. Masayuki Furukawa · 1 shared paper, 2025 · strength 0.16
  22. Motokazu Sugimoto · 1 shared paper, 2025 · strength 0.16
  23. Shugo Mizuno · 1 shared paper, 2025 · strength 0.16
  24. Shuji Suzuki · 1 shared paper, 2025 · strength 0.16
  25. Yuki Sunagawa · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.